Artwork for podcast Blueprints of Disruption
Pharmacare: We Almost There?
Episode 12625th April 2024 • Blueprints of Disruption • Rabble Rousers' Cooperative
00:00:00 00:58:15

Share Episode

Shownotes

Are we there yet?

In the wake of the Liberals 2024 Budget, we pulled Nik Barry-Shaw into the studio to unpack what it all means for the long fight for Pharmacare in Canada. Nik is a campaigner with the Council of Canadians.

All of our content is free - made possible by the generous sponsorships of our Patrons. If you would like to support us: Patreon

Follow us on Instagram

Resources:

Transcripts

Speaker:

Greetings friends. My name is Jess McLean and I'm here to provide you with some blueprints

Speaker:

of disruption. This weekly podcast is dedicated to amplifying the work of activists, examining

Speaker:

power structures and sharing the success stories from the grassroots. Through these discussions,

Speaker:

we hope to provide folks with the tools and the inspiration they need to start to dismantle

Speaker:

capitalism, decolonize our spaces and bring about the political revolution that we know

Speaker:

we need. Welcome Nick. Can you introduce yourself to our audience, please? Sure. My name is Nick

Speaker:

Berry Shaw. I'm the trade and privatization campaigner with the Council of Canadians. But

Speaker:

these days, my job title is probably more like a pharmacare campaigner. Trade and privatization.

Speaker:

That's a lot to unpack there alone. I know we came here to talk about pharmacare, but it

Speaker:

was like, oh, snap. The Council of Canadians, for folks who have no idea. What that is. Can

Speaker:

you give us the coolest notes? Yeah, the Council of Canadians was founded back in 1985, mainly

Speaker:

as a kind of a left nationalist organization opposed to free trade. And it was very much

Speaker:

in that kind of left nationalist mold. Certainly the person affiliated with the council that

Speaker:

people would know the best would be Maude Barlow, who was the chairperson for many, many years

Speaker:

and played it. a kind of pivotal role in the fight against free trade in the late 80s and

Speaker:

then against NAFTA and against the trade agreements like the MAI and the FTAA for those of that

Speaker:

generation for whom those acronyms mean something. These kind of free trade deals that were being

Speaker:

drafted by corporations in the years when history was supposed to have ended and they were just

Speaker:

going to kind of steamroll over everybody. And so the council played a pretty important role.

Speaker:

in organizing and mobilizing Canadians in those various fights in the 80s, late 80s, 90s, and

Speaker:

into the 2000s. And since then, you know, trade continues to be an important part of what the

Speaker:

Council does, but also fighting against especially healthcare privatization and fighting for the

Speaker:

expansion of the public healthcare system has always been a key element of what the Council

Speaker:

is about. And... So yeah, I think in general we are one of the few like genuinely membership-based

Speaker:

and membership-funded organizations out there that have a national reach. We get 92% of our

Speaker:

funding from our members, from donations. We have, I believe, 42 chapters across the country.

Speaker:

And certainly for me as someone coming to this from... from Montreal, I'm based in Montreal,

Speaker:

I grew up in Montreal, done, lived my whole life in Montreal, and so being involved in

Speaker:

kind of the radical left in Montreal, and I'm sure it's the case in many other places, it's

Speaker:

mostly rooted in universities, in larger cities, and often you don't have much reach outside

Speaker:

of those places, and so the council is very different in that regard, because we have chapters

Speaker:

in smaller and mid-sized towns, like... all across the country. And so as an organizer,

Speaker:

that's been really fascinating and interesting to be able to kind of be planning and working

Speaker:

on campaigns that have a different kind of scope than what I've been familiar with in previous

Speaker:

work. This is like totally off topic and I wasn't gonna bring it up, but the four Canadians in

Speaker:

the name makes me cringe, just like I'm a staunch. anti-nationalist. And I understand in the context

Speaker:

of the free trade and the way that, especially the CAW or the auto workers were being controlled

Speaker:

by an American union without their best interests. And so this left it, but you said the term,

Speaker:

so I have to talk about it. Right. I was like, you can't drop leftist nationalist without

Speaker:

maybe unpacking a little bit so folks understand because anything nationalist now, especially

Speaker:

with the word Canadian in it. has a real different flavor to it, if you know what I'm saying,

Speaker:

right? It kind of comes. Yes, it does. And so I wonder, does it still have a really nationalist

Speaker:

focus, or do you wanna maybe address what I've just thrown at you? No, no, I totally get that.

Speaker:

Yeah, the Council of Canadians, it's right there in the name. There have definitely been discussions

Speaker:

within the organization, within the membership about changing the name. I think those discussions

Speaker:

are always complicated, so we've stuck with what we have. I think ideologically, the organization

Speaker:

has kind of moved a substantial distance away from left nationalism. It's not as important

Speaker:

a part of our rhetoric, of our ideology, and so on, but I think at the same time, it's still

Speaker:

important for a good number of our members and supporters. But I think, yeah, like if you

Speaker:

follow... you know, the kind of trajectory of like what Maude Barlow was saying, you know,

Speaker:

and what she's done, you know, to the council's credit. I mean, I've only been working with

Speaker:

the council for like two years now, but I think you could kind of trace an arc where the council

Speaker:

kind of evolved out of a kind of more basic left nationalism where everyone from Maude

Speaker:

Barlow to Mel Watkins to Paul Martin, which... blew me away when I was reading. It was like

Speaker:

they were part of the founding group, you know, so it was a very like broad, and I would say

Speaker:

not actually that left nationalism in some ways at the beginning. And moved in a much more

Speaker:

internationalist direction, you know, various campaigns around water, which has been really

Speaker:

important for the council over the last, you know, decades. I've done a lot of work with

Speaker:

First Nations communities around these things. When what's a wet and was happening those shortly

Speaker:

before I joined the organization. I know the council was fairly involved in is happening.

Speaker:

Is happening. Well, yeah, there's ongoing, but when the rail blockades and stuff, when it

Speaker:

was at its peak, the council was fairly involved in that. I understand. And so, yeah, I think,

Speaker:

I think the name, I think, yeah, still poses a problem for some people. Yeah, I think it's

Speaker:

just kind of a. gut reaction for me at this point, even when I dig deep, it's just like

Speaker:

when I read it. Anytime someone uses the rhetoric actually of four Canadians when they're talking

Speaker:

about federal policy worries me because your citizenship actually isn't dependent on a lot

Speaker:

of federal programs, nor should it be, right? And so that's kind of politician talk, but

Speaker:

we don't wanna get too far off topic. We do really wanna unpack pharmacare and... the legislation

Speaker:

that recently passed, which, you know, arguably definitely a victory for those who've been

Speaker:

advocating for pharmacare, which has not seen any movement in a very, very long time, despite

Speaker:

many election promises by the victor. It's not like we were banking on a single party to win

Speaker:

there. The liberals have promised this for a long, long time. And so back in... Late February,

Speaker:

early, anyway, not that long ago, you wrote a piece, what I would describe as a victory

Speaker:

piece, a celebratory piece with cautionary tales. Definitely not like the NDP tweets that are

Speaker:

coming out today that have me raging where they're just claiming they've delivered pharmacare

Speaker:

and dental care and winter protection and all of these things that have just been delivered

Speaker:

to us today. It's far more complex than that. So I'm glad you're here to kind of get people.

Speaker:

to understand the legislation, and then we'll talk about the budget a little bit, and what

Speaker:

that means for PharmaCare, plus all kinds of goodies in between. But what excited you about

Speaker:

the legislation for PharmaCare, because there was a lot of ways it could have gone. I think,

Speaker:

yeah, first I should just say that the legislation has been introduced, but it hasn't been passed.

Speaker:

So now it's in second reading. I mean, I'm learning about all the arcane of parliamentary procedure

Speaker:

by working on this campaign, but it's gonna go to the committee and then it's gonna go

Speaker:

to third reading in the Senate. And so it'll probably get passed sometime like in the fall

Speaker:

of 2024. I think that's probably like an optimistic timeline, but the legislation that's been introduced.

Speaker:

Bill C-64, I think, is a victory for, you know, the Council of Canadians and for our allies

Speaker:

and the Canadian Health Coalition, the unions like the CLC that have been, you know, fighting

Speaker:

for this for many, many years, and a lot of the patient advocates and other organizations

Speaker:

that have been fighting for this stuff for a long time. And I think... what we were particularly

Speaker:

happy to see in there was first of all, it didn't have any out-of-pocket costs, right? So it's

Speaker:

what's called first dollar coverage in the legislation. So it means that when you go to the pharmacy

Speaker:

and you're getting medications that are covered by this national plan, you're going to get

Speaker:

them with your health card. You're not going to be paying with a credit card. And I think

Speaker:

that's- Michelle, I'd like to forward for a second. It's a good line. He said that to us.

Speaker:

It's a good line. I think we should rip it off. It's a good line. Find a different way to deliver

Speaker:

that. No, no, I think we should totally appropriate the... You're reclaiming it? ..the sloganeering

Speaker:

of the right when they come with a good one.

Speaker:

And in this case, it is actually true. I mean, I think the thing about Doug Ford is like,

Speaker:

yeah, that's how it should be, but it ain't what's going on with his healthcare privatization

Speaker:

schemes. quite the opposite. But so that was important. So the fact that there's no out

Speaker:

of pocket costs, I think that was very important. The fact that it's universal is huge, meaning

Speaker:

that everyone covers everybody. It doesn't cover only, the system we have now is this public-private

Speaker:

patchwork. Some people have workplace plans. Some people are covered by... public plans

Speaker:

that are run by the provinces, and some people have no coverage at all, and there's wildly

Speaker:

different levels of coverage. Sometimes you have a big copayment, sometimes you have a

Speaker:

huge deductible, so you basically don't get any money back before you pay huge amounts

Speaker:

out of pocket. And so it's a mess, and there's lots of people who not only fall through the

Speaker:

cracks, but a lot of people who, even with the coverage that they have, can't afford their

Speaker:

meds. This is like the means testing we talk a lot about on the show that really gets me

Speaker:

pissed off when means testing is introduced to any aspect of healthcare. It's a huge problem

Speaker:

because also income levels are really hard to gauge. They lack nuance, family size, cost

Speaker:

of living increases, or whether you're in an urban or rural setting, none of that seems

Speaker:

to matter. It's just a really arcane way to deliver something that everybody should have.

Speaker:

then it makes barriers too, right? Then there's paperwork and other steps that even if you

Speaker:

do qualify, you don't, because you don't understand or don't complete the process correctly. So

Speaker:

that absolutely is an important point for me too, because it's been the dental care. I mean,

Speaker:

I'm not even gonna talk about it, but. No, no, it's actually important to talk about dental

Speaker:

care because that was- Now you're gonna get us all wrong left. That was what, yeah. But

Speaker:

that was what the insurance industry, and that's what Big Pharma really wanted. Like if you

Speaker:

read their lobbying briefs that they were submitting to the Ministry of Health. For PharmaCare.

Speaker:

That's what they wanted for PharmaCare. For PharmaCare, they're kinda like in their inter-industry

Speaker:

meeting, because Pharma and the insurers are constantly meeting and convening strategy sessions

Speaker:

and thinking of how they can shape PharmaCare legislation. They were doing that even before

Speaker:

the Supply and Confidence Agreement kind of put PharmaCare back on the political agenda.

Speaker:

So they were gunning for something that would be basically a dental care style, means tested,

Speaker:

only covers the uninsured, or you have income cutoffs and so on. None of that, right? And

Speaker:

I think that's really hugely important. And it was a big defeat for the insurers. And if

Speaker:

you look at what their main lobbying industry association was saying afterwards, they were

Speaker:

saying, we have serious concerns, they're really upset with the... It felt like the government

Speaker:

hadn't listened to them and they'd been lobbying the health ministry like crazy in the lead

Speaker:

up. So, you know, I think that the universality is key because it really does entrench the

Speaker:

principles that, you know, make our public healthcare system so widely loved and so effective in

Speaker:

the pharmacare as it's gonna roll out going forward. Let's talk about that industry lobbying

Speaker:

a bit because although this was surprising that it didn't seem to take any of their input,

Speaker:

some of their lobbying has been very successful within the ministry, within the cabinet. The

Speaker:

Breach did a great article, we'll link in our show notes. You guys opened up about that in

Speaker:

your statement where heavy, heavy pressure. I don't think folks realize the amount of layers

Speaker:

of lobbying that are involved. Nick touched on it. being pharma and insurance companies

Speaker:

colluding and working together. We're talking about like entire teams of highly paid professionals

Speaker:

that spend their entire time and effort trying to pressure governments in different ways,

Speaker:

kind of like Nick does, but for evil, you know, and much bigger teams with a lot fancier offices,

Speaker:

I imagine. I hope because your money should be going elsewhere. But you know what I mean?

Speaker:

On top of that, they have think tanks and other kinds of policy type groups that do that work

Speaker:

for them or that they create themselves sometimes. It's just so much and they're usually quite

Speaker:

successful. So although I'm always very skeptical of any legislation passed these days, like

Speaker:

I, there are these pluses are really big considering. but you call them they a lot. Can we name some names?

Speaker:

Like we love to talk about blah blah, like when we're talking about other issues, we know who to really go after. Who are the biggest players in Canada

Speaker:

that are pushing for lesser pharma care? Yeah, that would be, I mean, there's the big name pharmaceutical corporations

Speaker:

like Pfizer, like Johnson & Johnson, like GSK, GlaxoSmithKline, AbV. You know, there's a fairly long list of them.

Speaker:

I've been compiling the list. I didn't want to hear that. I just need one. I have to focus

Speaker:

my answers. Oh, there's too many. And they have so many resources behind them. So I've been

Speaker:

tracking. They haven't even gotten into the insurers yet. No, no. So that's pharma. And

Speaker:

then they have their industry body, which is called Innovative Medicines Canada. And that

Speaker:

sort of is, you know, regroups all of these brand name drug manufacturers in Canada. And...

Speaker:

You know, the CEO of Innovative Medicines Canada is routinely recognized as one of the most

Speaker:

influential lobbyists on the Hill. And then on the insurance side, we have really like

Speaker:

three big insurers in Canada. We have Manulife, Canada Life, and Sun Life. Those are like the

Speaker:

big three. Another one that kind of stands out, because I've been going through the lobbying

Speaker:

data for a while now, is Greenshield Canada. which is surprising because it's close to some

Speaker:

of the union movement. They work a lot with Unifor and a lot of unions have their insurance

Speaker:

plans with Green Shields because it's technically a nonprofit, but they are part along with the

Speaker:

big three insurers. They actively participate in the industry lobbying group called the CLEA,

Speaker:

which is a very unfortunate acronym, Canadian Life and Health Insurance Association. So,

Speaker:

They are very involved and they've been lobbying as much as some of these really big players

Speaker:

that have like 10, 20 times the revenues. And so again, this is something I haven't, like

Speaker:

this pure speculation on my part, but I'm like, how the hell is this like small insurance company

Speaker:

that's supposedly nonprofit playing such a big role in fighting public single-payer pharma

Speaker:

care? They have run paid, like sponsored content. in the Globe and Mail. They did a day-long

Speaker:

seminar hosted by André Picard that they sponsored. They have done a pilot project that they announced

Speaker:

saying, you know, don't do a universal system. We're going to show you how to just do pharma

Speaker:

care for, you know, for the poorest of the poor. Oh, we know what that would look like. Yeah.

Speaker:

So. really and but presenting it as like this you know of course we care about the struggling

Speaker:

you know low-income workers and those are the people that we're doing this for and don't

Speaker:

do a universal thing that's just giving money to wealthy people so really bizarre kind of

Speaker:

class politics masking what is obviously an industry agenda so i'm like i know we know

Speaker:

that they've been funded by a pharmaceutical company we don't know which one right Because

Speaker:

it was anonymous and no one's done any digging I haven't had time to do any digging on that

Speaker:

but like obviously they're working hand in glove, right? Obviously like they're punching above

Speaker:

their weight because somebody is giving them money And so those are the really the two kind

Speaker:

of Those are the players on the two sides on the insurance side and the firm aside And yeah,

Speaker:

I mean we're up against a lot of money a lot of money a lot of yeah a lot of capitalist

Speaker:

power for sure, I don't like Have you ever seen the movie Thank You for Smoking? I haven't,

Speaker:

sounds good though. It follows the life of a lobbyist for the tobacco industry. He dines

Speaker:

with the head lobbyist for the firearms industry. And I think pharmaceuticals, I can't remember

Speaker:

what, but they were like three vices, I can't remember. And... You might appreciate it now

Speaker:

having to do what you do, but it does give me the impression it's just like one person lobbying

Speaker:

on behalf of all of these huge things. And that's really not what it's like now. I mean, maybe

Speaker:

it was in the 80s, but that is a huge conglomerate forced to be up against a member funded organization.

Speaker:

I imagine there's probably not a lot of groups dedicating massive amounts of resources to

Speaker:

grassroots, pharmacare organizing. And there's just so many issues to fight for. And yeah.

Speaker:

Yeah. I mean, this is an issue that the council has been pushing for in various ways since

Speaker:

2000. But going into, I guess shortly after the supply and confidence deal was signed,

Speaker:

and we were even working on a campaign on pharmacare before that. But with the supply and confidence

Speaker:

agreement, we were like, okay. This is an actual opportunity. We have a chance to fight for

Speaker:

something here. We know the liberals are very weak and they've only gotten weaker. They're

Speaker:

depending on the NDP to prop them up and they've made this formal commitment to pass legislation,

Speaker:

to bring legislation on pharmacare. And so, yeah, let's try to concentrate our energies

Speaker:

on that and let's try to. raise the temperature as much as possible. Let's try to be strategic.

Speaker:

So we did a lot of like mapping of writings and looking at who the MPs were that were really

Speaker:

on the bubble on the liberal side, looking at who's in cabinet and who is probably gonna

Speaker:

lose the next election. So like, you know, that versus like an MP in the Anglophone part of

Speaker:

Montreal. It's like, you know, they're not- Who doesn't need to listen to anybody. Yeah,

Speaker:

they don't need to listen to anybody. Except to whoever funds his election. Exactly, yeah.

Speaker:

I mean, they probably don't even need funding for their election. They're just going to get

Speaker:

a... The war chest is full. You're right. Yeah. So we did a lot of that kind of pre-planning

Speaker:

for the campaign. And yeah, I mean, I think it made sense. And I'm pretty happy with what

Speaker:

we've been able to achieve. I don't think it's, you know, immodest to say that we've been playing

Speaker:

an outsized role because we put the time in and we've been trying to, you know, doing a

Speaker:

lot of work. I think one of the orientations that we actually learned... in part from the

Speaker:

pharma industry itself was the importance of patient voices. And so making connections with

Speaker:

people who have diabetes, people who have a kid with a rare disease, you know, people who

Speaker:

have been through the struggle themselves, right, who have found themselves confronted with these

Speaker:

ridiculously high drug costs and in many cases have paid for it not only with out of pocket

Speaker:

but with their health, right. and who can speak to that of just how dire the need is for PharmaCare.

Speaker:

And so we've built relationships with a number of people like that who could be spokespeople.

Speaker:

And we organized an 18 city tour, PharmaCare kind of town halls, where we made sure to give

Speaker:

these people kind of a platform to speak out alongside experts. And yeah, and I think that

Speaker:

was sort of, we were in part drawing inspiration from the Machiavellian. kind of workings of

Speaker:

big pharma, right? Because they understand who their worst enemy is, right? They understand

Speaker:

that like the thing that is kryptonite for them is like people like Aaron Little, this woman

Speaker:

from Port Elgin, Ontario, whose daughter has a rare disease and a pharma company came along

Speaker:

and bought the rights to her drug and basically jacked up the price 3000% and was asking families

Speaker:

of kids with this rare... kidney disease to pay $300,000 a year to keep their kid alive,

Speaker:

basically. And what they do is they give money to the patients to advocate on their behalf.

Speaker:

So there are all these pharma-funded patient groups out there that pharma has basically

Speaker:

co-opted to get them to go out there and say, look, we need the provincial government to

Speaker:

cover this on their plan. we need insurers, private insurers to cover this. Because as

Speaker:

soon as you're charging hundreds of thousands of dollars for a drug, there's no actual market

Speaker:

for that, right? Like there's no one, no one has that kind of money to like, to pay for

Speaker:

the drugs. But so they use those patient voices to basically push their commercial interests.

Speaker:

And I think to neutralize criticism from these groups. But there's a ton of people, you know,

Speaker:

people like Erin Little who are out there. And in her case, to her credit, they tried to buy

Speaker:

her off. And she said, you know, fuck you. Like this is outrageous. This is bigger than me.

Speaker:

Yeah. And this is bigger than me. And she had a social conscience about it and was like,

Speaker:

yeah, you know, like she, she had people donating her money because, you know, she, and as she

Speaker:

put it, she was like, yeah, my daughter is this cute little blonde girl. So of course people

Speaker:

want to run GoFundMaze for her. But if like, if I was black, if my daughter was black, like

Speaker:

would they be doing that? You know? So, you know- It does leave a lot up to chance, right?

Speaker:

Or privilege. Yeah. Yeah, exactly. And so meeting and connecting with people like that and bringing

Speaker:

them into the campaign, in some cases people like Bill Swan, another patient advocate from

Speaker:

Nova Scotia who's been working on this stuff since the 80s, has COPD, ended up in hospital

Speaker:

as a young man because he couldn't get a puffer, because he lost coverage after he aged out

Speaker:

of his father's plan. You know, and these people aren't special in the sense that this stuff

Speaker:

happens to people every day. It's just happening all the time. There was a poll that was done

Speaker:

recently, and it showed 22% of Canadian households have someone who hasn't been able to afford

Speaker:

their medication in the last year. Right? So that's... Even with that experience level being

Speaker:

high, there's still a lot of Canadians or people in Canada that don't realize how bad the lack

Speaker:

of coverage is. because there are some provinces that cover seniors, for example. And, you know,

Speaker:

if you're lucky, you could go your entire life without needing regular medication. You kind

Speaker:

of go from maybe your parents paying or being covered for medication. You kind of skirt through

Speaker:

if you're lucky and you don't need it. And you just assume everybody is in the same situation

Speaker:

and they'd be horrified to know that there are now some, like, chemotherapy drugs that aren't

Speaker:

covered by OHIT. Anybody in Ontario knows what's... being covered is less and less and less. But

Speaker:

that brings me to one of the critiques that I'm sure even you have about the legislation

Speaker:

being introduced and the rollout, only including two classifications of drugs to begin with.

Speaker:

Those folks need with diabetes, as well as contraception of a few different forms. To my understanding,

Speaker:

it's not just a birth control pill. nor is it just insulin, right? So they're kind of categories

Speaker:

of drugs. That doesn't even cover some of the folks that you were just talking about, right?

Speaker:

Or the people that I was talking about. So how can we look at that critically, but also hopefully?

Speaker:

I think, yeah, I mean, I think it's a foot in the door. You know, we have a foothold kind

Speaker:

of towards... bigger program because the legislation does lay out a process for expanding it to

Speaker:

a bigger list of essential medicines, which most people who've looked at essential medicines,

Speaker:

it's usually like the kind of drugs that your family doctor, if you're lucky enough to have

Speaker:

one, will prescribe you. These are the most commonly prescribed drugs. So there is that

Speaker:

in the legislation, which is positive. But yeah, it started very small. And I think this is

Speaker:

partly the revenge of Big Pharma and the insurance industry is, you know, I'm sure that this is

Speaker:

something that the liberals, when they have those meetings with those lobbyists, they're

Speaker:

telling them, they're like, don't worry, we're going to give the people this much and no further,

Speaker:

you know. And even, I mean, you can hear it, right? Like, as soon as the legislation dropped,

Speaker:

as soon as it was introduced, Mark Holland, the liberal health minister, went out there

Speaker:

and said, you know, I'm not ideological. I'm not sure if we should continue with a public

Speaker:

single payer system, right? Even though report after report has shown that it's cheaper, it

Speaker:

provides better coverage, it will save us billions of dollars on drug costs. He still thinks we

Speaker:

don't have enough data. He says this is a proof of concept. We're doing a pilot project, right?

Speaker:

And we're going to see. And the example he cited as an interesting kind of alternative to what

Speaker:

we have been pushing for and what the NDP... to its credit had been pushing for in the negotiations.

Speaker:

Public single-payer pharmacare, the alternative is PEI. And PEI has a deal with the federal

Speaker:

government where they basically give a bunch of money to the provincial health plan, which

Speaker:

is fine. I mean, the federal government should be investing more in healthcare, but crucially,

Speaker:

it's not single-payer. And the importance of... a program being single payer is that if you

Speaker:

cover everybody and you have the federal government negotiating on everyone's behalf, you're able

Speaker:

to negotiate down the price of these drugs, right? And that's what big pharma does not

Speaker:

want to see. For so many reasons. That's what they're fighting tooth and nail. Because you

Speaker:

look when the announcement that we were going to have pharmacare legislation coming. came

Speaker:

out with the Supply and Conference Agreement back in March, 2022. I'm only imagining the

Speaker:

reaction. So you guys, your wheels started turning, but these folks are always thinking about Farbakar

Speaker:

already. They must've been like, oh shit. But that's the interesting thing is their response

Speaker:

was, we're pleased to hear this. And we hope that the federal government will go forward

Speaker:

and strengthen our public-private system, right? And so it's kind of weird because like, it

Speaker:

took me a while to understand this because it's like, why the... why the hell does Big Pharma

Speaker:

Care, who's paying? They just want the highest price for their jobs. That's a red flag, right?

Speaker:

Their response is a big red flag. That's the problem is they don't want a single payer public

Speaker:

system, because then they're gonna be in the same situation that they're in with virtually

Speaker:

every other country with a developed healthcare system other than the US, where you have some

Speaker:

kind of universal Pharma Care system and where the government negotiates centrally with these

Speaker:

pharmaceutical companies. and get significantly lower prices, right? In Canada, we're paying

Speaker:

the second highest prices in the world now. We were third for a long time. Now we've passed,

Speaker:

I believe it was Germany. And so we're second only to the US. We're paying the second highest

Speaker:

prices. And we have tons of people who don't have insurance. And we have tons of people

Speaker:

who are covered by, you know, really, yeah, really patchy, really inadequate in public

Speaker:

insurance or private insurance. So, you know, that's what they're fighting against, right?

Speaker:

And so they've always taken this outward stance of, you know, okay, yes, pharmacare, but work

Speaker:

within the existing system. And don't, you know, they try to claim that it's gonna blow up everything

Speaker:

else if we do this single payer system. So, OK, I want to go back. Now it's time to talk

Speaker:

about the budget. So I want to. Because my ears went up when you spoke about revenge from the

Speaker:

industry, you know, in this kind of delayed. rollout because the announcement was for 1.5

Speaker:

billion. Like that was the number that was always not always floated out but as part of these

Speaker:

budget announcements that we got teasers for. But then we find out it's actually over five

Speaker:

years with like less than 60 million for its first year and you folks have done the work

Speaker:

you've done the math you're telling us that it's about three billion to cover these to

Speaker:

drugs. So because when the announcement came, they asked Jogmeet Singh about it and he was

Speaker:

skeptical even then. He seemed to know that there would be lacking funds in the budget.

Speaker:

There was not much said about it at the time, but it was part of his initial announcement,

Speaker:

like not to really expect much in the 2024 budget itself. And to me, that was just like another

Speaker:

red flag. the reaction of the industry that you're talking about there plus the budget

Speaker:

announcements, the details. You want to react to all that now. The foundation is still there,

Speaker:

but there's a real risk that it's not adequate enough for longevity. Is that? Yeah, there's,

Speaker:

I think it's weird because I'm learning the nuances of budget process as we go. So there

Speaker:

is a possibility to kind of like up the amount of funding that is there for PharmaCare as

Speaker:

things go along. But it's definitely concerning. Like they should be announcing loud and clear,

Speaker:

you know, the federal government should be announcing loud and clear to the provinces that this is

Speaker:

going to be fully funded, that they're going to, you know, cover a significant chunk if

Speaker:

not all of the cost. I mean, like, you know... $3 billion on the federal budget of, I think

Speaker:

480 billion or something, it's like 0.6%. You know, it's a rounding error in the federal

Speaker:

budget. They could easily, easily tomorrow just cover the whole thing, right? And so the very

Speaker:

fact that we're having- I'm sure you could find some of those in there. Like, can we have that?

Speaker:

Like, is that possible? Anything that falls from the table, can you kind of beef up pharmacare

Speaker:

a little bit? Yeah, I think I was looking at like, when they announced that they were gonna

Speaker:

have the- federal civil service cut back on outside consultants and international travel.

Speaker:

I think like the annual savings from that were something like five billion over three years

Speaker:

or something. I mean, it's just like they're spending that much money just on external consultants

Speaker:

and fucking flying people to conferences. Because I'll tell you what to do. I'll do it for free

Speaker:

because I'm so pissed off about everything, you know, just yeah. That must have been frustrating

Speaker:

because like when you, when I read your article back from February, and rightfully so, you

Speaker:

know, it was really celebratory. And you deserved a moment, but then I feel like I get, I get

Speaker:

frustrated. Usually I blame the NDP and I focus my rage there because the messaging sometimes,

Speaker:

and I'm... I'm bad for this. Like I know we should celebrate any victories because we don't

Speaker:

get very many. I understand the importance for the psyche, but I feel like that's just like

Speaker:

not my job. So I apologize for everyone out there who feels like I just, I shit on every

Speaker:

victory, but I feel like there's always gotta be someone in the room that's going, we gotta

Speaker:

keep going. Please keep going. Like, please do not applaud these people. Like, please,

Speaker:

like, please just look at them like Oliver and be like, can I please have some more? Like,

Speaker:

but. but in a much more assertive way, right? Like at a time where your foot should be on

Speaker:

the gas, when that foot is in the doors is not when you kind of lean back, it's when you push

Speaker:

forward really aggressively to get in and make it stay there. Because we know the liberals

Speaker:

aren't gonna win the next election unless something crazy happens. And we know that the conservatives

Speaker:

want nothing to do with pharmacare, let alone a single payer. So, There's two risks, right,

Speaker:

that I want to focus on because you gotta mitigate them somehow. The provinces could be a barrier,

Speaker:

right? They're, the rollout has complications there with getting them to agree, especially

Speaker:

with this paltry sum, as well as the threat of the conservatives if it's not implemented.

Speaker:

I've mentioned this before, but it's really important. Kathleen Wynne did this to us in

Speaker:

Ontario, so folks should remember. We got all this great labor legislation, but she only

Speaker:

introduced it when she knew she was about to lose an election. So it was—it might have been

Speaker:

an attempt to win that election, but I think, like, the writing was on the wall. It was just

Speaker:

to kind of placate the movements, I think, to get them to pull back a little bit and almost

Speaker:

all of it. I think all of it. I would be hard pressed to think of one bit of that bill, including

Speaker:

the minimum wage that got canceled, that remained, and they knew it wouldn't because a lot of

Speaker:

it had delayed rollouts or only applied to a small target group at the beginning. And so

Speaker:

no one really missed it when they axed it, except the minimum wage. That really should have pissed

Speaker:

people off. And it did. You know what I'm saying? If something is entrenched, it's delivered

Speaker:

to as many people as possible, it becomes way more difficult to come in and rip it away from

Speaker:

them. That becomes a real political liability for people. But if it's just this piecemeal

Speaker:

thing that's not working, dental care is gone. They're not gonna be able to save that from

Speaker:

the conservatives, because it's a fucking mess. And people will probably applaud them because

Speaker:

of the bad media around it. So what can we do to farm a care now?

Speaker:

Like, what's your plan of attack now that you've got this budget? I think you mentioned the

Speaker:

provinces and I think, yeah, that's sort of, is one of the elements of the legislation that

Speaker:

is a double-edged sword, right? So it's good in the sense that it's not like dental care,

Speaker:

it's actually a public program that will be administered publicly. So like Dental Care,

Speaker:

they got Sun Life to be the company that is administering, they basically took out a plan,

Speaker:

you know, with Sun Life for all of the people who meet the criteria that they set out, which

Speaker:

is crazy complicated. For a universal program, it makes sense, and they're running it through

Speaker:

provincial drug plans, and it kind of works like the health transfer where it's like the

Speaker:

feds give you this money and you basically have to level up the coverage that you offer people

Speaker:

to be. They have to, yeah. Because some of the health transfers have not a lot of strengths.

Speaker:

Again this is one of the weaknesses of the legislation is it's very clear for diabetes drugs and for

Speaker:

contraceptives that it has to be first dollar, it has to know out of pocket costs, it has

Speaker:

to cover everybody. And then it says, okay, and then we're going to expand to essential

Speaker:

medicines within a year of passing it, which will, chances are, happen. after the October

Speaker:

2025 election, unfortunately, but it'll be coming. But there it's a little, there's a bit of gray

Speaker:

area, right? And so if you read what like the insurance industry people are saying, or the

Speaker:

pharmaceutical funded think tanks, they're like, okay, yeah, well, next phases will be not universal,

Speaker:

will be not single pair, will, you know, and so they're angling for that. So that's something.

Speaker:

That's so hard to imagine. What a complicated mess that you'd have two sets of drugs on one

Speaker:

and then a whole different system set up for the other. That seems like valuable and expensive.

Speaker:

I think the real end game, the immediate goal for us from here till the federal election

Speaker:

is, can we get as many provinces as possible to sign on? and have as many people across

Speaker:

the country as possible receiving their contraceptives, receiving their diabetes drug for free through

Speaker:

their health card, you know, and can we make that happen before October 2025? Because if

Speaker:

this is still a program that is just on paper, you know, there's nothing easier for a future

Speaker:

Polio government to walk in and just tear it up, you know. So, okay, pharmacare is done.

Speaker:

Taking away people's access to insulin, to their diabetes drugs, to their free contraceptives,

Speaker:

it's going to be harder. I'm not saying, I mean, Polio could do it, but it's going to be harder.

Speaker:

And we'll, you know, I think we'll face that fight when we get there, if we get there. But

Speaker:

I think the priority right now is to have as many provinces get on board and roll this out.

Speaker:

We know a number of them are already favorable. I mean, the obvious ones being BC and Manitoba.

Speaker:

where the NDP is in power provincially. Doug Ford says he needs to see some details and

Speaker:

the usual suspects, Alberta and Quebec, what is their deal? I mean, before they even see

Speaker:

any details, they're like, no, fuck you, feds. Yeah, I mean, Quebec. We love being a thorn

Speaker:

in your side, take that. Quebec is a foregone conclusion. I mean, I guess for Daniel Smith's

Speaker:

UCP government too, been doing some digging on this because there are some lobbyists who

Speaker:

have been hired by Shoppers, which is owned by Loblaws, and they have been lobbying the

Speaker:

provincial government on PharmaCare, the Alberta government on PharmaCare. I'm like, you have

Speaker:

to clarify it, because that asshole was the first person to meet with Ford when he won,

Speaker:

so they're everywhere. They're everywhere. And so yeah, we've focused pretty much exclusively

Speaker:

on the insurance companies and Big Pharma through this campaign, but... I mean, there's just

Speaker:

so much legitimate rage against law laws, and they're clearly playing a role in pushing provinces

Speaker:

to kind of to fight back or reject the national pharma care plan that I think, yeah, we're

Speaker:

going to be we're going to be digging more into that and putting out some research soon on

Speaker:

that. I feel like at this rate, Shoppers Drug Mart is going to be the single. provider of

Speaker:

medication for Ontarians. I mean, they had that deal with manual life that they had to, I think,

Speaker:

retract because people got so pissed off, but it just gives people an idea of how entrenched.

Speaker:

We've talked about Gail and Weston even in private clinics, medical clinics, and buying the real

Speaker:

estate that's underneath them, as well as our groceries and rental units. So the sway within

Speaker:

government, as you can imagine, is massive. So that's just like another layer your opponents,

Speaker:

but... It's interesting, because when Galen Weston and the Loblaws people get called to

Speaker:

testify, and they say, why are your food prices so damn high? And they say, oh, our profits

Speaker:

are coming from pharmaceuticals. Don't worry. Nick is sitting over there giving him the finger.

Speaker:

Yeah, we fucking know. No, thanks. And everyone's supposed to be relieved at their grocery store.

Speaker:

Oh, well, it's not here. It's when I go get my medication that they're really fucking me.

Speaker:

And... Or when I need money at the bank, they're getting my fees there. Because yeah, like that

Speaker:

was some sort of out for them. They're so disconnected from why we hate them. But let them remain

Speaker:

oblivious. And that's the kind of thing, like the deal that they signed with Manulife was

Speaker:

basically they were going to funnel everyone who has a plan with Manulife into their stores.

Speaker:

And if we move towards a universal public single pair where people were covered no matter where

Speaker:

they are and no matter what kind of job they have, that would be impossible. Those deals

Speaker:

would not be on the table for law laws. And they would also probably face scrutiny for

Speaker:

the kinds of dispensing fees they're charging at their pharmacies because the federal government

Speaker:

will be involved in that too. So, yeah, they have some interests that in seeing this national

Speaker:

pharmacare project fail. See, I know everyone's talking about housing a lot. I mean, everybody,

Speaker:

well, we are because we can't afford it, but politicians are using housing as a real hot

Speaker:

button issue. But when you talk about the level of lobbying that's involved with the pharmacare

Speaker:

and that one lobbyist for the innovative medicines of Canada being like the most influential person

Speaker:

on the Hill, I can only imagine there's gonna be a lot centered on this and... a lot riding

Speaker:

on it for these lobbyists. Their money is clearly going to be in one camp here. I know they like

Speaker:

to hedge their bets, which is great, and they still will. But they'll have a real incentive

Speaker:

here to get the conservatives to win, because the liberals I don't think are any position

Speaker:

to back out of this or even to go back to a multi- what do you call it when it's not single

Speaker:

payer? Multi-payer? Mixed or public-private. Yeah. It's so melty. Dual pair. They refer

Speaker:

to it as dual pair. That's their... Dual pair, okay. Yeah, although it's really like tens

Speaker:

of thousands of pairs because you have so many different plans. Yeah, I can't like see the

Speaker:

liberals kind of having... That would just be a little bit messy. So I expect folks to hear

Speaker:

about this on the campaign trail and the conservatives to try to make it a way... Any issues that

Speaker:

arise from pharmacare a bit of a wedge issue. the way that they're trying to do with dental.

Speaker:

But I think the important part there that you're talking about rolling it out to as many people

Speaker:

as possible is, although it's two categories of drugs, there are a lot of people and families

Speaker:

impacted by diabetes. And I think everyone can understand why it's so important to have that

Speaker:

medication. But it's impossible to measure the amount of people that would take advantage

Speaker:

of the free contraception. So we might have numbers on people who use it or of the age

Speaker:

that one would use it. But I think that the cost of contraception has been a deterrent,

Speaker:

you know, an immeasurable factor in a lot more. Cause I've seen a lot of people kind of, and

Speaker:

this is what happens when you have rollouts like this or means testing, it pits people

Speaker:

against one another on a level. So there's people who have... drugs they can't afford and they

Speaker:

want a reason to include their drug and maybe not birth control, right? Like why is birth

Speaker:

control so important? So I know why it's so important. Do you wanna like reflect on that?

Speaker:

And because right wing or left wing, there's a lot of people out there that need contraception

Speaker:

that would have better lives if they could control the amount of births. that they had to experience,

Speaker:

or pregnancies rather, that they had to experience? Yeah, I mean, it's a cost barrier for a lot

Speaker:

of women, I think especially lower income women, and especially for things like IUDs, which

Speaker:

are included in the list of things that will be covered under this PharmaCare plan. The

Speaker:

cost barrier is pretty substantial. So yeah, having access to those more effective, less

Speaker:

likely to fail forms of birth control is huge. The government cited, I think, a figure of

Speaker:

like nine million women and other people who need contraceptives that would benefit from

Speaker:

this. So I think, yeah, I think it's going to affect a lot of people and I think diabetes

Speaker:

likewise, there's tons of people who have diabetes and I think people will understand pretty easily

Speaker:

why this is necessary. But I think... You're talking about a dynamic of like this kind of

Speaker:

negative solidarity that we often, working class people often get into, right? Where it's like,

Speaker:

how come he has it so fucking good? What about me? You know, he should be suffering like I

Speaker:

am. Right? Like that's kind of like, and you see it all the time, public sector versus private

Speaker:

sector workers and stuff. And I think also people, it's easy to look at birth control as not life

Speaker:

saving, even though it is. It definitely is for many, many people, not just to prevent

Speaker:

a pregnancy, but. for issues that they have with their health, they use the birth control

Speaker:

pill, I could go on it. We have, but it's one of those easy ones where you could just be

Speaker:

like, literally this medication keeps me breathing and it's not covered, but something that a

Speaker:

condom could do. This is a real kind of uneducated mentality that's out there, but yeah, it's

Speaker:

definitely reminiscent of the same things that we find reasons to punch across instead of

Speaker:

up. Yeah, but what's been interesting, and I think is a dynamic that works in the opposite

Speaker:

direction, is you have some patient groups, and even ones that get some money from the

Speaker:

pharmaceuticals, have been coming out. I don't know how cynical maybe they're trying to get

Speaker:

inside the policy process by doing this, but they've been saying, well, we should be next.

Speaker:

Cancer drugs need to be next, or drugs for heart disease should be next, and so on. And so it's

Speaker:

like... And of course, like, yeah, there's a program there that's changing people's lives

Speaker:

and giving them much better access to their medicines without having to pay huge amounts

Speaker:

out of pocket. It's like, of course, you want to get on board and most people don't care,

Speaker:

you know, like about the politics of the of the program. They just see that this is something

Speaker:

that is better and that could make things better for them. So, yeah, I think that's something

Speaker:

that, you know, like in the immediate aftermath of the introduction of the bill, there was

Speaker:

a number of like. radio national kind of call-in shows. And a lot of people were pretty clear-eyed

Speaker:

about it. They were just like, yeah, I know this isn't gonna do anything for me, but I'm

Speaker:

still really happy and I hope this program expands. And I think that's the kind of dynamic that

Speaker:

is positive, the kind of positive solidarity that people see happening and that we're gonna

Speaker:

try to encourage as much as possible from here on out. Because I think that's how we can.

Speaker:

win things and I think yeah we're used to kind of you know the Ontario experience that you're

Speaker:

referring to where we kind of have this hail mary gains that are thrown at us by a failing

Speaker:

government and then they get snatched away just as quickly but there are other instances where

Speaker:

things have been built up and you know if people are organized enough they can fight to keep

Speaker:

them and even expand them. We just got to do the work I don't know it's tough. but we gotta

Speaker:

do it. What is the work then for people listening that want their healthcare drugs covered or

Speaker:

they understand the importance of this program and the timeframe in which they need to operate

Speaker:

in? What should they be doing other than staying in touch with the Council of Canadians? Yeah,

Speaker:

I think, you know. We've been working to have people get out and do canvassing. We're kind

Speaker:

of like, we didn't expect to get this far, quite frankly. I love the honesty. Yeah, no, no.

Speaker:

Because considering what we're up against, right? I was pretty prepared to just write a very

Speaker:

angry analysis post being like, this legislation is crap. And then it's like, whoa, okay, it's

Speaker:

actually not crap. It's actually, you know, in line as weaknesses and stuff, but it's in

Speaker:

line with what we were campaigning for. So that was a big surprise. But yeah, I mean, I think

Speaker:

we're in a phase now where we're trying to build closer relationships with the groups that have

Speaker:

been fighting for contraceptives and reproductive health. and reaching out to groups of people

Speaker:

who in the diabetes community who aren't being funded because some of the bigger groups are

Speaker:

being funded by the pharmaceutical industry, but there are kind of networks and groups of

Speaker:

people. That's some shady shit. Yeah. Oh, it's shady as hell. I mean, you can't imagine how

Speaker:

shady... They're like tenant rights groups being funded by the landlords. It is exactly that.

Speaker:

Oh, that's another episode, Nick. That has such cringe worthiness. But I love the idea of building

Speaker:

a wider coalition, because quite often folks try to reinvent the wheel or do that work that's

Speaker:

really already been done, meaning organizing around a health issue or whatever it is that's

Speaker:

completely tied to what you're advocating for. That's really where folks start to make grounds,

Speaker:

because... Yeah, resources can be tight, so people power is important. I mean, and I think,

Speaker:

I think like at an individual level, like, I mean, yeah, it's tough to do things individually.

Speaker:

I think in general, you know, if you're not gonna join the Council of Canadians, join another

Speaker:

group that's campaigning on pharmacare. I think it's important. You need to get, have organizations

Speaker:

and you need to get together with people in your community. So we're trying to facilitate

Speaker:

that and work with as many groups of people as possible, either through our chapters or

Speaker:

even in places where we don't have chapters. But I think, you know, also just talking to

Speaker:

people like, you know, probably everybody knows, has maybe people in their family or in close

Speaker:

friends who have diabetes, just like, you know, if you educate yourself a bit about the bill

Speaker:

and talk to them and see if they know that this is coming and talk to them about it. Because

Speaker:

like I think some of the polling I've seen is like 50% of people don't even know like anything

Speaker:

about the pharmacare legislation, right? And, you know, had this experience. shortly after

Speaker:

the legislation dropped where We got a we got an op-ed in the Toronto Star kind of laying

Speaker:

out why we thought this was this was good And it was a victory against Big Pharma and the

Speaker:

insurance companies and I wanted to go buy it and I happened to be in Toronto In a kind of

Speaker:

north part of Toronto. I can't remember the name It was it wasn't North York But it was

Speaker:

not far from there and I just went to all the all the corner stores I was gonna say Dippin'

Speaker:

Earths the corner stores in the area trying to get a paper, trying to get a Toronto star.

Speaker:

And like nobody had newspapers, you know. We call them convenience stores. Convenience stores,

Speaker:

there you go. It's not always on the corner. Yeah, and I went to like three of them and

Speaker:

I asked them and they were like, oh no, people don't read the newspaper. It's just like, yeah.

Speaker:

It's behind a paywall for me. I never see the, I'm up in the boonies here, North America,

Speaker:

Toronto, but, aw. So you still don't have a copy of that? I did, I got a copy. Do I have

Speaker:

a copy? Yeah, I got a copy. I actually. But your point was we don't, we just watch CP24

Speaker:

here in Ontario. I think it's on in the hospital waiting rooms for us. So we're there a long

Speaker:

time. That's where we're supposed to get our news. Yeah. So, so yeah. So there's, there's

Speaker:

a lot of, you know, just like basic education of like people within your family. If you happen

Speaker:

to be, you know, know more about this issue, just like ask around and share, share stuff.

Speaker:

Yeah. I actually got this. It's very silly. I got this copy, paper copy of the Toronto

Speaker:

Star out of the garbage of a shopper's drug mart. Because I got one the day after. I was

Speaker:

like, do you have yesterday's paper? And they're like, well it's in the garbage. I don't care.

Speaker:

I'll take every copy. That's so funny you say that too because I totally get it. Santiago,

Speaker:

our producer, he's got a piece coming out for Humber. They do a magazine every year. And

Speaker:

I'm like a mom, I feel like I'm just like, you make sure you get me a good copy, not a crease

Speaker:

copy. Don't fold it and put it in your bag. Maybe get another copy. Don't forget to get

Speaker:

your parents a copy. And he's like, oh no, I know, I know. And you know, we're excited for

Speaker:

its release. It matters. It's not silly. It's important. Thank you, Nick, for coming on and

Speaker:

for doing this advocacy work. It's a bit of a grind, but we will link, folks. to your campaigns,

Speaker:

the op-ed you've referenced, and a whole bunch of the work that you folks are doing. And yeah,

Speaker:

folks can check out Council of Canadians, not for Canadians, I made that mistake at the beginning

Speaker:

of the episode, this is much better, of Canadians. And also you mentioned Health Coalitions, we've

Speaker:

interviewed members from the Ontario Health Coalition. but they're also in a lot of small

Speaker:

towns too, including the big cities. But if you can't find a chapter for the Council of

Speaker:

Canadians, that is definitely another way that you can push back against this, you know, private

Speaker:

industry lobbying and be part of the good guys. But thank you, Nick, for coming on the show

Speaker:

too and brightening my view of PharmaCare, because like anything that comes out of this Casa deal,

Speaker:

I just, you know, Heavy bias. I don't want to believe anybody in government anymore. And

Speaker:

so sometimes I need a calm head to show me those bright spots, the things that are worth fighting

Speaker:

for there. Yeah, well, glad to be a hopeful voice. That is a wrap on another episode of

Speaker:

Blueprints of Disruption. Thank you for joining us. Also a very big thank you to the producer

Speaker:

of our show, Santiago Helu-Quintero. Blueprints of Disruption is an independent production

Speaker:

operated cooperatively. You can follow us on Twitter at BPofDisruption. If you'd like to

Speaker:

help us continue disrupting the status quo, please share our content and if you have the

Speaker:

means, consider becoming a patron. Not only does our support come from the progressive

Speaker:

community, so does our content. So reach out to us and let us know what or who we should

Speaker:

be amplifying. So until next time, keep disrupting.

Chapters

Video

More from YouTube